Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
35 /100
MEDIUM RISK
Score updated Oct 13, 2026

IOVA — Iovance Biotherapeutics, Inc. Dilution Risk Tracker

Track IOVA dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track IOVA — Get alerts when the score changes →

As of October 13, 2026, Iovance Biotherapeutics, Inc. (IOVA) has a DilutionWatch DilutionScore of 35/100, rated MEDIUM dilution risk. Iovance Biotherapeutics, Inc. has a market capitalization of $6.60B, 452.97M shares outstanding, 289 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
26
💰 Cash Runway
65
📊 Float Risk
7
⚠️ Warrant Exposure
15
🔄 Convertible Debt
15

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 7%
💰 Capital Raise model 15%
• Under 12 months cash (9mo)
🔔 Track IOVA — Get forecast alerts →

Market Data

Market Cap$6.60B
Shares Outstanding452.97M
Float387.98M
Cash$297.67M
Debt$47.78M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore35/100DilutionWatch score record
Shares Outstanding452.97MVerified float table or market cache
Public Float387.98MVerified float table or market cache
Market Cap$6.60BMarket data cache
Cash Runway9.0 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 6.

Recent SEC source mix: 3 1, 4 4, XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 18.6% shares (2026Q1 vs prior)
289 institutional holders · 325.19M shares
#1 VANGUARD CAPITAL MANAGEMENT LLC 33.24M shares
#2 BlackRock, Inc. 31.08M shares
#3 MHR FUND MANAGEMENT LLC 28.97M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest64.83M
Days to Cover2.8
% of Float16.7%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2019-02-28
3 FORM3 2026-10-02
4 INSIDER TRANSACTION 2026-10-02
4 INSIDER TRANSACTION 2026-09-10
4 INSIDER TRANSACTION 2026-09-10
Full SEC filing analysis available with free account →

Recent News

Factual IOVA Dilution Snapshot

Iovance Biotherapeutics, Inc. (IOVA) has a DilutionScore of 35/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

IOVA's DilutionScore is currently 35/100 (Medium risk), with 2 score changes tracked over 89 days. The score deteriorated from 45/100 (Medium risk).

Period Score Risk Level Duration
Oct 10 – Oct 13, 202635/100MEDIUM4 days
Aug 22 – Oct 09, 202645/100MEDIUM49 days
Jul 16 – Aug 21, 202648/100MEDIUM36 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

IOVA shares outstanding have increased 8.4% from 411.96M (Mar 2026) to 446.50M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 12, 2026446.50M387.99M▲ 1.28%
May 09, 2026446.50M383.09M▲ 8.38%
Apr 21, 2026411.96M353.45M▲ 0.01%
Mar 09, 2026411.96M353.41M▼ 0.05%
Mar 08, 2026411.96M353.58M▼ 0.01%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track IOVA Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment IOVA files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking IOVA — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for IOVA
IOVA FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.